Vivo Capital

company

About

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

  • 51 - 100

Details

Industries
Finance,Financial Services,Health Care,Venture Capital
Founded date
Jan 1, 1996
Number Of Employee
51 - 100
Operating Status
Active
Investor Type
PE,Venture Capital

The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts.
The firm operates as a multi-fund investment platform, covering growth equity, private
equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

Investments

Number of Investments
Number of Lead Investments
16
4
Vivo Capital has made 16 investments. Their most recent investment was on Nov 29, 2022, when Rgenta Therapeutics raised $52M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $52M Biotechnology
Oct 27, 2022 Neocis
Series D $40M Dental
Jul 6, 2022 Tebra
Series B $72M Electronic Health Record (EHR)
Seed $18M Biotechnology
May 6, 2021 Aerobiotix
Series Unknown $25M Health Care Yes